Search Results 41-50 of 11244 for Polycythaemia / erythrocytosis

  1. A Study To Evaluate The Effectiveness, Safety, Pharmacokinetics And Pharmacodynamics Of Idasanutlin Monotherapy In Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

    ... Polycythemia Vera. Print details. Share; Facebook ... Polycythemia vera (PV). ... NOTE: Major criterion number b) may not be required in cases with sustained ...

  2. High red blood cell count When to see a doctor - Mayo Clinic

    Anemia and polycythemia. In: Rosen's Emergency Medicine: Concepts and Clinical Practice. 10th ed. Elsevier; 2023. http://www.clinicalkey.com. Accessed Oct ...

  3. High red blood cell count When to see a doctor - Mayo Clinic

    Anemia and polycythemia. In: Rosen's Emergency Medicine: Concepts and Clinical Practice. 10th ed. Elsevier; 2023. http://www.clinicalkey.com. Accessed Oct ...

  4. A Study To Evaluate IONIS-TMPRSS6-LRx (ISIS 702843) In Patients With Polycythemia Vera - Mayo Clinic

    A Study To Evaluate IONIS-TMPRSS6-LRx (ISIS 702843) In Patients With Polycythemia Vera ... polycythemia vera. Participation eligibility. Participant ...

  5. Safety And Efficacy Of Momelotinib In Subjects With Polycythemia Vera Or Essential Thrombocythemia - Mayo Clinic

    This open-label study is to determine the safety and efficacy of momelotinib in participants with either polycythemia vera (PV) or essential thrombocythemia ...

  6. A Study of Aplidin for Treating Patients with Primary Myelofibrosis, Post Polycythemia Vera or Essential Thrombocythemia Myelofibrosis - Mayo Clinic

    Clinical Trials · A Study of Aplidin for Treating Patients with Primary Myelofibrosis, Post Polycythemia Vera or Essential Thrombocythemia Myelofibrosis · More ...

  7. A Study Using Momelotinib In Transfusion-Dependent Adults With Primary Myelofibrosis, Post-Polycythemia Vera Or Post-Essential Thrombocythemia Myelofibrosis - Mayo Clinic

    A Study Using Momelotinib In Transfusion-Dependent Adults With Primary Myelofibrosis, Post-Polycythemia Vera Or Post-Essential Thrombocythemia Myelofibrosis.

  8. A Study of Whole Genome Sequencing in Hereditary Erythrocytosis for New Diagnostic Test Development - Mayo Clinic

    The purpose of this study is to use whole genome sequencing to identify more causal pathways and variants responsible for hereditary erythrocytosis. These ...

  9. Study To Evaluate The Long-term Safety Of Rusfertide (PTG-300) In Subjects With Polycythemia Vera - Mayo Clinic

    The purpose of this study is to assess long-term safety and efficacy of rusfertide in subjects with polycythemia vera. Subjects who complete dosing with ...

  10. Rusfertide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Rusfertide injection is used to treat erythrocytosis (high amount of red blood cells) in patients with polycythemia vera. This medicine is available only ...